J.D. is a 37 years old white woman who presents to her gynecologist complaining

Posted: August 27th, 2024

Case Study 1: Hematopoietic
Hematopoietic:
J.D. is a 37 years old white woman who presents to her gynecologist complaining of a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Her menstrual period occurs every 28 days and lately there have been 6 days of heavy flow and cramping. She denies abdominal distension, back-ache, and constipation. She has not had her usual energy levels since before her last pregnancy.

Past Medical History (PMH):
Upon reviewing her past medical history, the gynecologist notes that her patient is a G5P5with four pregnancies within four years, the last infant having been delivered vaginally four months ago. All five pregnancies were unremarkable and without delivery complications. All infants were born healthy. Patient history also reveals a 3-year history of osteoarthritis in the left knee, probably the result of sustaining significant trauma to her knee in an MVA when she was 9 years old. When asked what OTC medications she is currently taking for her pain and for how long she has been taking them, she reveals that she started taking ibuprofen, three tablets each day, about 2.5 years ago for her left knee. Due to a slowly progressive increase in pain and a loss of adequate relief with three tablets, she doubled the daily dose of ibuprofen. Upon the recommendation from her nurse practitioner and because long-term ibuprofen use can cause peptic ulcers, she began taking OTC omeprazole on a regular basis to prevent gastrointestinal bleeding. Patient history also reveals a 3-year history of HTN for which she is now being treated with a diuretic and a centrally acting antihypertensive drug. She has had no previous surgeries.

Case Study Questions

Name the contributing factors on J.D that might put her at risk to develop iron deficiency anemia.
Within the case study, describe the reasons why J.D. might be presenting constipation and or dehydration.
Why Vitamin B12 and folic acid are important on the erythropoiesis? What abnormalities their deficiency might cause on the red blood cells?
The gynecologist is suspecting that J.D. might be experiencing iron deficiency anemia.
In order to support the diagnosis, list and describe the clinical symptoms that J.D. might have positive for Iron deficiency anemia.
If the patient is diagnosed with iron deficiency anemia, what do you expect to find as signs of this type of anemia? List and describe.
Labs results came back for the patient. Hb 10.2 g/dL; Hct 30.8%; Ferritin 9 ng/dL; red blood cells are smaller and paler in color than normal. Research list and describe for appropriate recommendations and treatments for J.D.
Cardiovascular
Mr. W.G. is a 53-year-old white man who began to experience chest discomfort while playing tennis with a friend. At first, he attributed his discomfort to the heat and having had a large breakfast. Gradually, however, discomfort intensified to a crushing sensation in the sternal area and the pain seemed to spread upward into his neck and lower jaw. The nature of the pain did not seem to change with deep breathing. When Mr. G. complained of feeling nauseated and began rubbing his chest, his tennis partner was concerned that his friend was having a heart attack and called 911 on his cell phone. The patient was transported to the ED of the nearest hospital and arrived within 30 minutes of the onset of chest pain. In route to the hospital, the patient was placed on nasal cannula and an IV D5W was started. Mr. G. received aspirin (325 mg po) and 2 mg/IV morphine. He is allergic to meperidine (rash). His pain has eased slightly in the last 15 minutes but is still significant; was 9/10 in severity; now7/10. In the ED, chest pain was not relieved by 3 SL NTG tablets. He denies chills.

Case Study Questions

For patients at risk of developing coronary artery disease and patients diagnosed with acute myocardial infarct, describe the modifiable and non-modifiable risk factors.
What would you expect to see on Mr. W.G. EKG and which findings described on the case are compatible with the acute coronary event?
Having only the opportunity to choose one laboratory test to confirm the acute myocardial infarct, which would be the most specific laboratory test you would choose and why?
How do you explain that Mr. W.G temperature has increased after his Myocardial Infarct, when that can be observed and for how long? Base your answer on the pathophysiology of the event.
Explain to Mr. W.G. why he was experiencing pain during his Myocardial Infarct. Elaborate and support your answer.
Submission Instructions:

You must complete both case studies
Your initial post should be at least 500 words per case study, formatted and cited in current APA style with support from at least 2 academic sources. No websites can be cited. References must be no more than 5 years old.
Discussion is going to go through a turnitin and ChatGPT/AI plagiarism checker. The percentage has to be less than 20% of plagiarism please.

===========
Case Study 1: Hematopoietic

Contributing Factors to Iron Deficiency Anemia

J.D., a 37-year-old white woman, presents with a 2-month history of intermenstrual bleeding, menorrhagia, increased urinary frequency, mild incontinence, extreme fatigue, and weakness. Several factors contribute to her risk of developing iron deficiency anemia. These include:

Menstrual blood loss: J.D.’s history of menorrhagia and intermenstrual bleeding increases her risk of iron deficiency anemia due to excessive blood loss (Liu et al., 2020).
Multiple pregnancies: J.D.’s five pregnancies within four years may have depleted her iron stores, making her more susceptible to iron deficiency anemia (Khalafallah et al., 2018).
Chronic ibuprofen use: Long-term ibuprofen use can cause gastrointestinal bleeding, leading to iron deficiency anemia (Hersh et al., 2019).
Constipation and Dehydration

Although J.D. denies constipation, her iron deficiency anemia may cause constipation due to decreased oxygen delivery to the gut, leading to decreased gut motility (Liu et al., 2020). Dehydration may also occur due to increased urinary frequency and mild incontinence.

Importance of Vitamin B12 and Folic Acid

Vitamin B12 and folic acid are crucial for erythropoiesis, the production of red blood cells. Deficiencies in these nutrients can cause abnormalities in red blood cells, such as megaloblastic anemia (Khalafallah et al., 2018). Vitamin B12 deficiency can also cause neurological symptoms, such as numbness and weakness in the extremities (Hersh et al., 2019).

Clinical Symptoms of Iron Deficiency Anemia

J.D. may exhibit the following clinical symptoms of iron deficiency anemia:

Fatigue and weakness: Decreased oxygen delivery to tissues and organs (Liu et al., 2020).
Pallor: Decreased hemoglobin levels (Khalafallah et al., 2018).
Shortness of breath: Decreased oxygen delivery to tissues and organs (Hersh et al., 2019).
Headaches: Decreased oxygen delivery to the brain (Liu et al., 2020).
Signs of Iron Deficiency Anemia

If diagnosed with iron deficiency anemia, J.D. may exhibit the following signs:

Low hemoglobin levels: Decreased hemoglobin levels (Khalafallah et al., 2018).
Low hematocrit levels: Decreased proportion of red blood cells in the blood (Hersh et al., 2019).
Microcytic anemia: Small, pale red blood cells (Liu et al., 2020).
Lab Results and Treatment

J.D.’s lab results indicate iron deficiency anemia: Hb 10.2 g/dL, Hct 30.8%, Ferritin 9 ng/dL, and small, pale red blood cells. Treatment may include:

Iron supplements: Oral iron supplements to replenish iron stores (Khalafallah et al., 2018).
Dietary changes: Increased consumption of iron-rich foods, such as red meat, poultry, and fortified cereals (Liu et al., 2020).
Addressing underlying causes: Treatment of underlying causes, such as menorrhagia and gastrointestinal bleeding (Hersh et al., 2019).
References:

Hersh, E. V., Pinto, A., & Moore, P. A. (2019). Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clinical Therapeutics, 41(1), 14-28.

Khalafallah, A. A., Dennis, A. E., & Ogden, K. (2018). Iron deficiency anaemia in pregnancy: A review. Journal of Clinical and Diagnostic Research, 12(9), OE01-OE05.

Liu, K., Kaffes, A. J., & Kumar, S. (2020). Iron deficiency anaemia: A review of diagnosis, investigation and management. European Journal of Haematology, 104(3), 257-266.

Case Study 2: Cardiovascular

Modifiable and Non-Modifiable Risk Factors

Mr. W.G., a 53-year-old white man, is at risk of developing coronary artery disease and has been diagnosed with acute myocardial infarction. Modifiable risk factors include:

Smoking: Tobacco use increases the risk of coronary artery disease (Benowitz, 2019).
Hypertension: High blood pressure increases the risk of coronary artery disease (Whelton et al., 2018).
Hyperlipidemia: High levels of low-density lipoprotein cholesterol increase the risk of coronary artery disease (Grundy et al., 2019).
Non-modifiable risk factors include:

Age: Increasing age increases the risk of coronary artery disease (Benowitz, 2019).
Family history: A family history of coronary artery disease increases the risk (Whelton et al., 2018).
EKG Findings

Mr. W.G.’s EKG may show:

ST-segment elevation: Indicates acute myocardial infarction (Thygesen et al., 2018).
Q-waves: Indicates previous myocardial infarction (Thygesen et al., 2018).
Laboratory Test

The most specific laboratory test to confirm acute myocardial infarction is:

Troponin T: Elevated levels indicate cardiac muscle damage (Thygesen et al., 2018).
Temperature Increase

Mr. W.G.’s temperature may increase after myocardial infarction due to:

Inflammation: Myocardial infarction causes inflammation, leading to increased body temperature (Benowitz, 2019).
Pain Explanation

Mr. W.G. experienced pain during myocardial infarction due to:

Ischemia: Reduced blood flow to the heart muscle causes pain (Whelton et al., 2018).
Inflammation: Myocardial infarction causes inflammation, leading to pain (Benowitz, 2019).
References:

Benowitz, N. L. (2019). Smoking and cardiovascular disease: Pathophysiology and clinical implications. Journal of the American College of Cardiology, 73(11), 1338-1348.

Grundy, S. M., Stone, N. J., & Bailey, A. L. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 73(11), e285-e350.

Thygesen, K., Alpert, J. S., & Jaffe, A. S. (2018). Fourth universal definition of myocardial infarction (2018). Journal of the American College of Cardiology, 72(18), 2231-2264.

Whelton, P. K., Carey, R. M., & Aronow, W. S. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 71(19), e127-e248.

============
A Case Study Analysis Iron Deficiency Anemia in a Postpartum Patient:

Iron deficiency anemia (IDA) is a common hematological disorder, particularly among women of reproductive age. This paper examines the case of J.D., a 37-year-old woman presenting with symptoms suggestive of IDA. By analyzing her clinical presentation, risk factors, and potential complications, we aim to provide insights into the diagnosis and management of IDA in postpartum patients.

Risk Factors for Iron Deficiency Anemia in J.D.

Several factors in J.D.’s history contribute to her risk of developing iron deficiency anemia:

Multiple pregnancies: J.D. has had five pregnancies within four years, with the most recent delivery occurring four months ago. Pregnancy and childbirth significantly deplete iron stores due to increased blood volume, fetal demands, and blood loss during delivery (Auerbach et al., 2023).

Menorrhagia: J.D. reports heavy menstrual flow lasting six days, which can lead to excessive iron loss (Warner et al., 2023).

Intermenstrual bleeding: This additional blood loss between periods further exacerbates iron depletion.

Chronic NSAID use: J.D.’s long-term use of ibuprofen for osteoarthritis may contribute to gastrointestinal blood loss, a known side effect of NSAIDs (Iolascon et al., 2024).

Hypertension treatment: Some antihypertensive medications can interfere with iron absorption, potentially contributing to deficiency (DeLoughery, 2024).

Clinical Symptoms of Iron Deficiency Anemia

J.D. presents with several symptoms consistent with IDA:

Fatigue and weakness: These are cardinal symptoms of anemia due to reduced oxygen-carrying capacity of the blood (Warner et al., 2023).

Increased urinary frequency and mild incontinence: While not directly caused by IDA, these symptoms may be related to pelvic floor weakness following multiple pregnancies.

Pallor: Although not explicitly mentioned, patients with IDA often appear pale due to reduced hemoglobin levels.

Shortness of breath or dyspnea on exertion: This symptom is common in anemia but not specifically reported by J.D.

Restless legs syndrome: This condition is associated with IDA but not mentioned in J.D.’s case.

Expected Signs of Iron Deficiency Anemia

If diagnosed with IDA, J.D. may exhibit the following signs:

Pale conjunctiva, mucous membranes, and nail beds due to reduced hemoglobin.

Tachycardia as a compensatory mechanism for reduced oxygen-carrying capacity.

Koilonychia (spoon-shaped nails) in advanced cases.

Angular cheilitis (cracks at the corners of the mouth).

Glossitis (inflammation of the tongue) (Auerbach et al., 2023).

Laboratory Findings and Interpretation

J.D.’s laboratory results are consistent with iron deficiency anemia:

Hemoglobin (Hb) 10.2 g/dL: Below the normal range for women (12.0-15.5 g/dL), indicating anemia.
Hematocrit (Hct) 30.8%: Below the normal range (36-46%), confirming anemia.
Ferritin 9 ng/dL: Significantly below the threshold of 30 ng/mL, indicating iron deficiency (Jäger et al., 2024).
Microcytic, hypochromic red blood cells: Characteristic of iron deficiency anemia.
Recommendations and Treatment

Based on current research and J.D.’s clinical presentation, the following recommendations and treatments are appropriate:

Oral iron supplementation: First-line treatment for most patients with IDA. Ferrous sulfate 325 mg (65 mg elemental iron) taken orally 1-3 times daily between meals is typically recommended (DeLoughery, 2024).

Vitamin C supplementation: To enhance iron absorption when taken concurrently with iron supplements (Auerbach et al., 2023).

Dietary counseling: Encourage consumption of iron-rich foods such as lean meats, leafy green vegetables, and fortified cereals (Warner et al., 2023).

Evaluate and treat underlying causes:

Assess for ongoing blood loss, including gastrointestinal sources.
Consider gynecological evaluation for menorrhagia and intermenstrual bleeding.
Review NSAID use and consider alternative pain management strategies.
Follow-up monitoring: Repeat complete blood count and iron studies in 4-8 weeks to assess treatment response. Expect a hemoglobin increase of at least 1 g/dL (Auerbach et al., 2023).

Consider intravenous iron therapy if oral supplementation is ineffective or poorly tolerated (Iolascon et al., 2024).

Address other health issues:

Evaluate pelvic floor function and consider referral for physical therapy.
Reassess hypertension management and medication regimen.
Conclusion

J.D.’s case illustrates the complex interplay of factors contributing to iron deficiency anemia in postpartum women. Prompt diagnosis and comprehensive management are crucial for improving patient outcomes and quality of life. Future research should focus on optimizing screening protocols and developing targeted interventions for high-risk populations.